148 related articles for article (PubMed ID: 17350957)
1. Dual role for SUMO E2 conjugase Ubc9 in modulating the transforming and growth-promoting properties of the HMGA1b architectural transcription factor.
Li Y; Lu J; Prochownik EV
J Biol Chem; 2007 May; 282(18):13363-71. PubMed ID: 17350957
[TBL] [Abstract][Full Text] [Related]
2. Ubc9 interacts with chicken ovalbumin upstream promoter-transcription factor I and represses receptor-dependent transcription.
Kobayashi S; Shibata H; Kurihara I; Yokota K; Suda N; Saito I; Saruta T
J Mol Endocrinol; 2004 Feb; 32(1):69-86. PubMed ID: 14765993
[TBL] [Abstract][Full Text] [Related]
3. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins.
Edberg DD; Adkins JN; Springer DL; Reeves R
J Biol Chem; 2005 Mar; 280(10):8961-73. PubMed ID: 15591590
[TBL] [Abstract][Full Text] [Related]
4. A mass spectrometric study on the in vitro methylation of HMGA1a and HMGA1b proteins by PRMTs: methylation specificity, the effect of binding to AT-rich duplex DNA, and the effect of C-terminal phosphorylation.
Zou Y; Webb K; Perna AD; Zhang Q; Clarke S; Wang Y
Biochemistry; 2007 Jul; 46(26):7896-906. PubMed ID: 17550233
[TBL] [Abstract][Full Text] [Related]
5. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
Akhter MZ; Sharma A; Rajeswari MR
Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
[TBL] [Abstract][Full Text] [Related]
6. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
Hsieh YL; Kuo HY; Chang CC; Naik MT; Liao PH; Ho CC; Huang TC; Jeng JC; Hsu PH; Tsai MD; Huang TH; Shih HM
EMBO J; 2013 Mar; 32(6):791-804. PubMed ID: 23395904
[TBL] [Abstract][Full Text] [Related]
7. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
Zhang J; Goodson ML; Hong Y; Sarge KD
J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
[TBL] [Abstract][Full Text] [Related]
8. RWD Domain as an E2 (Ubc9)-Interaction Module.
Alontaga AY; Ambaye ND; Li YJ; Vega R; Chen CH; Bzymek KP; Williams JC; Hu W; Chen Y
J Biol Chem; 2015 Jul; 290(27):16550-9. PubMed ID: 25918163
[TBL] [Abstract][Full Text] [Related]
9. The UBC9 E2 SUMO conjugating enzyme binds the PR-Set7 histone methyltransferase to facilitate target gene repression.
Spektor TM; Congdon LM; Veerappan CS; Rice JC
PLoS One; 2011; 6(7):e22785. PubMed ID: 21829513
[TBL] [Abstract][Full Text] [Related]
10. A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.
Xu J; Watkins T; Reddy A; Reddy ES; Rao VN
Int J Oncol; 2009 Apr; 34(4):939-49. PubMed ID: 19287951
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group A1 protein: a new coregulator of peroxisome proliferator-activated receptor-γ-mediated transrepression in the vasculature.
Bloch M; Prock A; Paonessa F; Benz V; Bähr IN; Herbst L; Witt H; Kappert K; Spranger J; Stawowy P; Unger T; Fusco A; Sedding D; Brunetti A; Foryst-Ludwig A; Kintscher U
Circ Res; 2012 Feb; 110(3):394-405. PubMed ID: 22207709
[TBL] [Abstract][Full Text] [Related]
12. SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1.
Lin CH; Liu SY; Lee EH
Oncogene; 2016 Feb; 35(5):595-607. PubMed ID: 25867063
[TBL] [Abstract][Full Text] [Related]
13. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
Kim EJ; Park JS; Um SJ
Biochem Biophys Res Commun; 2008 Dec; 377(3):952-6. PubMed ID: 18955028
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.
Zou Y; Wang Y
J Proteome Res; 2007 Jun; 6(6):2304-14. PubMed ID: 17455969
[TBL] [Abstract][Full Text] [Related]
15. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
Lin JY; Ohshima T; Shimotohno K
FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
[TBL] [Abstract][Full Text] [Related]
16. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
[TBL] [Abstract][Full Text] [Related]
17. Dynamin interacts with members of the sumoylation machinery.
Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
[TBL] [Abstract][Full Text] [Related]
18. Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity.
Zhang Q; Wang Y
J Proteome Res; 2007 Dec; 6(12):4711-9. PubMed ID: 17960875
[TBL] [Abstract][Full Text] [Related]
19. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
20. Post-translational modification of POU domain transcription factor Oct-4 by SUMO-1.
Zhang Z; Liao B; Xu M; Jin Y
FASEB J; 2007 Oct; 21(12):3042-51. PubMed ID: 17496161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
